Created and managed the sales and marketing department for this IPA model physicians organization. As my responsibilities evolved, I established a credentialing department and process for our member-physicians in accordance with NCQA and JCAHO mandates. I also worked on contracting with both the physicians and our affiliated managed care organizations.

As a result of my success in the field and my ability to train others on managed care, I was selected for this six-month home office position that was extended to nine-months because of my abilities. As a member of the US Managed Markets marketing team, I managed multiple projects and marketing initiatives supporting US Managed Markets and the managed care field such as strategic planning, pull-through sales pieces, and value-added products. · Involved in the creation of the new Strategic Planning Process (SPP) established to increase the 78% total access our products cumulatively enjoy with formularies across the country · Trained all 83 members of the US Managed Markets field force on the SPP · Worked with the cardiology team to implement managed care strategies for the launch of Vytorin · Involved with the respiratory team to assist them in the upcoming launch of Asmanex and the re-launch of Proventil HFA

* 150% increase in total volume from pain management prescribers. * Track record of promotion with increased levels of responsibility. * Diverse understanding of managed markets and its payors – commercial, Medicare, and Medicaid.

* Responsible for the marketing and sales of a long-acting opioid for pain management. This territory encompassed Northern Oakland County in suburban Detroit. Prior to the purchase of Alpharma by King Pharmaceuticals, my territory covered most of lower Michigan including Grand Rapids, Kalamazoo, Battle Creek, Muskegon, St. Joseph, and Jackson. In this position I earned the Directors Club award in 2010 for sales achievements.

* I sold pharmaceutical products in the respiratory and allergy therapy class such as antihistamines, nasal steroids, antibiotics, antihyperlipidemics, and long and short acting beta agonists to physicians and pharmacists in the Flint territory. I called on physicians at their offices, in hospitals, and urgent care clinics. * · The Flint District ranked 2nd out of 39 districts in the North Central Region in 2002 and 2003 * · Territory strategies enabled Nasonex to be ranked 1st in the Region in 2002 and 2nd in 2003 * · Two primary products (Clarinex and Nasonex) finished in the top 5% nationally in market share growth * · Implemented a new call plan during September and October 2003 which saw our Nasonex and Clarinex business lead the nation in total new prescription share change of 7.2% and 3.0% respectively * · Began successful negotiations with area hospitals to get Foradil on its formulary * · Member of the first Eastern Area Talent Development program for district management

Providing solutions on data strategies and data contracting for specialty product launches – including data exhibits, KPI development, data contracting strategies, and RFP creation for this international specialty data aggregation and reporting expert. Design, implement, and manage multiple projects with payers and key stakeholders. Collaborated in over 6 product launches and developed future state aggregation SOP with new client aggregation wins.

Design, lead, and execute trade and distribution strategy for pharmaceutical clients of all sizes and types. Projects include specialty, traditional retail, and digital. - Successfully negotiated agreements with Big 3 wholesalers (AmerisourceBergen, Cardinal, McKesson), secondary wholesalers, specialty distributors, and group purchasing organizations (GPOs) of all types and sizes (Premier, Vizient, MHA, Onmark, ION, etc.). - Creation of limited distribution specialty network that allows clients to provide specialty therapies to patients by utilizing a network independent of the large specialty pharmacies to save on costs and sustaining quality care. Network includes specialty mail order, specialty brick and mortar, and hybrid pharmacy locations.